Frédéric Duchesne
Director/Board Member bei CEGEDIM
Profil
Frédéric Marie Duchesne currently works at Cegedim SA, as Director from 2019, Cenexi SAS, as Director from 2021, Phinex SAS, as Director from 2021, SOPHiA GENETICS SAS, as Director, and Phixen SAS, as Director from 2021.
Mr. Duchesne also formerly worked at Pierre Fabre SA, as Chief Executive Officer-Pharmaceuticals Division from 2015 to 2019, Pierre Fabre Médicament SAS, as Chairman & CEO-Pharmaceutical Division from 2010 to 2019, Bristol-Myers Squibb SARL, as CEO-United Kingdome & Vice President-Europe, Quantum Genomics SA, as Director, Pierre Fabre Ltd., as Director, Biodexa Pharmaceuticals Plc, as Non-Executive Director from 2019 to 2020, Sanofi, as Production Manager, and Groupe GlaxoSmithKline SAS, as Vice President-Primary Care France.
Aktive Positionen von Frédéric Duchesne
| Unternehmen | Position | Beginn |
|---|---|---|
| CEGEDIM | Director/Board Member | 01.01.2019 |
Cenexi SAS
 Cenexi SAS Pharmaceuticals: MajorHealth Technology Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France. | Director/Board Member | 01.01.2021 |
SOPHiA GENETICS SAS
 SOPHiA GENETICS SAS Data Processing ServicesTechnology Services Part of SOPHiA GENETICS SA, SOPHiA GENETICS SAS provides data processing, hosting and related activity services. The private company is based in Montpellier, France. | Director/Board Member | - |
Phinex SAS
 Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France. | Director/Board Member | 12.03.2021 |
Phixen SAS
 Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The private company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Director/Board Member | 12.03.2021 |
Ehemalige bekannte Positionen von Frédéric Duchesne
| Unternehmen | Position | Ende |
|---|---|---|
| QUANTUM GENOMICS | Director/Board Member | 23.01.2023 |
| BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 31.03.2020 |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Corporate Officer/Principal | 30.05.2019 |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | 01.01.2019 |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SANOFI | Commercial Services |
| CEGEDIM | Technology Services |
| QUANTUM GENOMICS | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Distribution Services |
Cenexi SAS
Cenexi SAS Pharmaceuticals: MajorHealth Technology Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France. | Health Technology |
Phinex SAS
Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France. | Finance |
SOPHiA GENETICS SAS
SOPHiA GENETICS SAS Data Processing ServicesTechnology Services Part of SOPHiA GENETICS SA, SOPHiA GENETICS SAS provides data processing, hosting and related activity services. The private company is based in Montpellier, France. | Technology Services |
Pierre Fabre Ltd.
 Pierre Fabre Ltd. Household/Personal CareConsumer Non-Durables Part of Pierre Fabre Participations SAS, Pierre Fabre Ltd. is a British company that develops innovative solutions for the well-being of everyone, from health to beauty. The private company is based in London, UK. The company's flagship products include purifying mist, fortifying shampoo, dry shampoo, and anti-dandruff shampoo for hair care, as well as treatments for chronic diseases such as heavy legs, urinary disorders, allergies, type 2 diabetes, and anemia. The company also offers a range of iconic brands under the Pierre Fabre brand, including Eau Thermale Avène, Ducray, Dexeryl, Eludril, Elgydium, and Naturactive. The company has a best practices guide for relations with patient associations to ensure responsible and sound decision-making. | Consumer Non-Durables |
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The private company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Finance |
Groupe GlaxoSmithKline SAS
 Groupe GlaxoSmithKline SAS Financial ConglomeratesFinance Part of GSK Plc, Groupe GlaxoSmithKline SAS is an investment holding French company. The private company is based in Rueil-Malmaison, France. | Finance |
